https://www.madinamerica.com/non-drug-therapies-adults-bipolar-disorder/
Non-drug therapies adults- bipolar disorder - Mad In America
mad in americadrug therapiesbipolar disordernonadults
https://www.madinamerica.com/non-drug-therapies-adult-psychotic-disorders/
Non-Drug Therapies: Adult Psychotic Disorders - Mad In America
mad in americadrug therapiespsychotic disordersnonadult
https://diabetesvoice.org/en/news/clinical-trials-obesity-and-type-2-diabetes-management/
ADA Scientific Sessions: new drug therapies for obesity and type 2 diabetes management - Diabetes...
Jul 6, 2023 - Clinical trial findings could be game changers in treating people with obesity and type 2 diabetes and slow this public health crisis.
scientific sessionsnew drugdiabetes managementada
https://www.madinamerica.com/non-drug-therapies-adult-depression/
Non-drug Therapies: Adult Depression - Mad In America
mad in americadrug therapiesnonadultdepression
https://www.madinamerica.com/non-drug-therapies-ptsd/
Non-drug therapies-Adult PTSD - Mad In America
mad in americadrug therapiesnonadultptsd
https://royalanniversarytrust.org.uk/winners/vital-work-on-hiv-drug-therapies/
Vital work on HIV drug therapies - Royal Anniversary Trust
Jan 17, 2022 - Recent data suggests that there are approximately 36.9 million people worldwide living with HIV and AIDS, of which 1.8 million are children, meaning that this...
hiv drugvitalworktherapiesroyal
https://www.pharmaadvancement.com/market-moves/advanced-drug-delivery-systems-transforming-modern-therapies/
Advanced Drug Delivery Systems Transforming Modern Therapies
Apr 28, 2026 - Explore advanced drug delivery systems transforming modern therapies through targeted delivery, controlled release and bioavailability in pharma development.
drug delivery systemsadvancedtransformingmoderntherapies
https://www.pharmaceutical-technology.com/news/merck-kgaa-remepy-collaboration-drug-digital-therapeutic-combination/
Merck KGaA and Remepy join forces to develop combo drug-digital therapies - Pharmaceutical...
Apr 28, 2026 - Merck KGaA and Remepy will work in tandem to develop drug-digital therapy combinations for a rare cancer indication.
merck kgaa
https://pmc.ncbi.nlm.nih.gov/articles/PMC4112860/
Constipation-predominant irritable bowel syndrome: A review of current and emerging drug therapies...
Irritable bowel syndrome (IBS) is a highly prevalent medical condition that adversely affects patient quality of life and constitutes a significant economic...
irritable bowel syndrome
https://www.drugtargetreview.com/exploring-liver-disease-therapies-/602556.article
Exploring liver disease therapies | Article | Drug Target Review
Mar 12, 2026 - Ochre Bio is at the forefront of therapeutic innovation, focusing primarily on liver diseases. Their core mission revolves around the development of RNA...
drug target reviewliver diseaseexploringtherapiesarticle
https://corporate.thermofisher.com/us/en/index/newsroom/Our-stories/tufts-center-study-integrated-drug-development-services-new-therapies-patients.html
Tufts Center study shows integrated drug development services could speed delivery of new therapies...
drug development services
https://www.drugtargetreview.com/topics/drugs-and-therapies
Drugs and therapies | Topics | Drug Target Review
drugs and therapiestopicstargetreview